Get the Stockscreener App
3.16
9.20%
-0.32
Painreform Ltd stock is traded at $3.16, with a volume of 143.83K.
It is down -9.20% in the last 24 hours and up +5.69% over the past month.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
See More
Previous Close:
$3.48
Open:
$3.35
24h Volume:
143.83K
Relative Volume:
0.04
Market Cap:
$2.76M
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.4426
EPS:
-7.14
Net Cash Flow:
$-6.69M
1W Performance:
+12.06%
1M Performance:
+5.69%
6M Performance:
-52.12%
1Y Performance:
-93.42%
1-Day Range:
$3.10
$3.3599
1-Week Range:
$3.10
$5.4699
52-Week Range:
$1.7272
$61.20
Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
3.16 | 2.76M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Painreform Ltd Stock (PRFX) Latest News
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings - Benzinga
Painreform Executes Definitive Agreement To Acquire Deepsolar, Marking A Unique Expansion Opportunity - Marketscreener.com
US Stocks Mixed; NY State Business Activity Rises In February - Benzinga
PainReform to Acquire AI-Driven Solar Analytics Platform DeepSolar From BladeRanger; Shares Up Pre-Bell - Marketscreener.com
Bladeranger sells Deepsolar platform to Painreform - גלובס
PainReform acquires AI solar analytics firm DeepSolar By Investing.com - Investing.com South Africa
PainReform stock soars on DeepSolar acquisition - Investing.com India
PainReform acquires AI solar analytics firm DeepSolar - Investing.com India
PainReform enters definitive agreement to acquire DeepSolar - TipRanks
PainReform Diversifies with Acquisition of AI Solar Platform DeepSolar - TipRanks
PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity - GlobeNewswire
PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity - Benzinga
Bladeranger divests Deepsolar to Painreform in strategic move - Globes
Apollon Wealth Management LLC Makes New $43,000 Investment in PainReform Ltd. (NASDAQ:PRFX) - Defense World
TEVA Stock Drops Over 5% Amid Financial Struggles - GuruFocus.com
Canopy Growth (CGC) Stock Drops Amid Financial Concerns - GuruFocus.com
Sonoma Pharmaceuticals (SNOA) Stock Surges Amid Industry Decline - GuruFocus.com
AMRN Stock Drops Amid Market Volatility - GuruFocus.com
PainReform (NASDAQ:PRFX) Stock Quotes, Forecast and News Summary - Benzinga
Stock market news: Nvni Group +254.36%, Allurion Technologies +153.92% among top gainers during mid day trading - Business Upturn
PainReform (NASDAQ:PRFX) Stock Price Down 3.6% – What’s Next? - Defense World
PainReform Ltd. Gains $3.17 Million from Warrant Exercise - TipRanks
Maxim Group Downgrades PainReform (PRFX) - MSN
PainReform Faces Setback in Phase 3 Trial for PRF-110 - Yahoo Finance
Stock market news: Siyata Mobile -90.00%, PainReform -29.18% among biggest losers during mid day trading - Business Upturn
PainReform Ltd. Provides Further Update on Phase 3 Clinical Trial of PRF-110 - Marketscreener.com
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110 - GlobeNewswire
PainReform's PRF-110 Trial Shows Mixed Results: Strong 48-Hour Pain Relief But Misses Primary Endpoint - StockTitan
PainReform down 38% after resuming trading - Nasdaq
Wall Street Holidays next week: NYSE, Nasdaq to remain closed on THESE days - Qrius
Cronos Group (CRON) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.18% - Investing.com UK
Dow Surges 100 Points, Carnival Earnings Top Views - Benzinga
BP and Iraq agree on technical terms for Kirkuk oilfield redevelopment - Yahoo! Voices
Skechers expands presence in Czech Republic with new concept store - Yahoo! Voices
Why the dollar is the most decentralized currency - Yahoo Finance
Fed's hawkish tilt has emerging markets scurrying to save currencies - Yahoo Canada Finance
Siga Technologies (SIGA) Stock Surges Over 5% Amid Market Activi - GuruFocus.com
Lamb Weston stock fried over Q2 miss, guidance cut, new CEO - Yahoo Finance
Wall Street-Heavily Traded - WDRB
Mortgage rates perk up, snapping three weeks of declines - Yahoo Finance
The trade controls US could enact while navigating China chip war - Yahoo Finance
Bitcoin drops after Powell says Federal Reserve 'not allowed' to own the cryptocurrency - Yahoo! Voices
Fed cuts reverse repo rate by wider margin than funds rate target - Yahoo Canada Finance
Current economy won't 'allow for a proper easing cycle': Economist - Yahoo Finance
Nasdaq, 'super-bullish' sentiment, bitcoin: Market Takeaways - Yahoo Finance
Stock market today: Wall Street trims its stellar gains as Nvidia's star dims again - Yahoo Canada Finance
Broadcom stock eases on post-earnings rally as Nvidia tumbles - Yahoo Finance
Air Canada eyes strong revenue growth by 2028, banks on robust leisure travel demand - Yahoo Canada Finance
Natural gas stocks are this expert's top pick, not 'overvalued' tech stocks - Yahoo Finance
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.23%
3.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):